Intas Pharma bags another overseas co
Mint New Delhi|January 08, 2025
Gujarat-based drug-maker Intas Pharmaceuticals Ltd, which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment Authority (ADIA) as its investors, has signed a deal to acquire a biologic medication brand from US-based Coherus Biosciences.
Sreeja Biswas

Intas Pharma has agreed to buy Udenyca brand through its US specialty division, Accord BioPharma, for up to $558.4 million (nearly ₹4,800 crore), according to a press release.

Udenyca is the brand name for medication pegfilgrastim-cbqv, a bone marrow stimulant used to treat low white blood-cell counts in patients who take cancer medications.

Denne historien er fra January 08, 2025-utgaven av Mint New Delhi.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

Denne historien er fra January 08, 2025-utgaven av Mint New Delhi.

Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.

FLERE HISTORIER FRA MINT NEW DELHISe alt
Mint New Delhi

Portfolio chaos: A teacher's quest from clutter to clarity

How Singh turned around his finances to secure his future with low-cost professional advice

time-read
4 mins  |
January 24, 2025
Mint New Delhi

Maruti Suzuki to up prices of models

Maruti Suzuki India Ltd (MSIL) on Thursday said it will hike prices by up to ₹32,500 across various models to partially offset the rise in input costs.

time-read
1 min  |
January 24, 2025
Mint New Delhi

Etonhurst to raise ₹500 cr real estate fund

Etonhurst Capital Partners is set to raise its first real estate fund, targeting residential redevelopment projects in Mumbai, according to a senior executive.

time-read
1 min  |
January 24, 2025
Mint New Delhi

American employees have lost their labour market leverage

Their pandemic gains are over as the power balance tilts away

time-read
3 mins  |
January 24, 2025
Mint New Delhi

There's a Need to Reimagine MGNREGA for a Modern Economy

The two decades since the passage of the act have seen tremendous changes

time-read
3 mins  |
January 24, 2025
Mint New Delhi

CCI ban on WhatsApp data-sharing on hold

No relief on ₹213 crore fine; experts say order undermines CCI's authority

time-read
2 mins  |
January 24, 2025
Mint New Delhi

India will clock fastest growth rate: Andhra CM Naidu at Davos

Andhra Pradesh chief minister N. Chandrababu Naidu has said that India's golden era has started and the country will clock the fastest growth rate.

time-read
1 min  |
January 24, 2025
Mint New Delhi

Companies Go For Corporate NPS As Traditional Plans Fade

Provident fund and gratuity seen as inadequate, while superannuation funds aren't portable

time-read
3 mins  |
January 24, 2025
Mint New Delhi

HUL needs a magic wand for recovery after subdued Q3

Not fast-moving

time-read
1 min  |
January 24, 2025
Mint New Delhi

JSW Defence, Telangana ink MoU

JSW Defence has signed an agreement with the Telangana government to set up a facility in the state for manufacturing unmanned aerial systems.

time-read
1 min  |
January 24, 2025